Search

everythinglearnresearchcommunity

for

Search:↓

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

Two men experienced hair regrowth while being treated with immune globulin for other health issues, but there were also side effects.

Large doses of glucocorticoids are not suitable for general use in treating severe alopecia areata due to inconsistent results and risks.

Intralesional steroid injections can effectively treat calcinosis and ulcers in scleroderma.

A patient with "strawberry gingivitis" improved after correct treatment for Granulomatosis with polyangiitis, highlighting the need for early diagnosis.

A rare scalp condition causing hair loss and cysts in young men can be treated effectively with a specific steroid injection.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

Myeloid-derived suppressor cells help control autoimmune cells and promote hair regrowth in alopecia areata.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Systemic corticosteroids may effectively treat follicular mucinosis.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

Bone marrow-derived cells contribute to skin tumors, suggesting new treatment targets for non-melanoma skin cancers.

Collagen VII helps skin heal and stay strong, sirolimus may lower skin cancer risk in kidney transplant patients, high-molecular-mass hyaluronan helps naked mole rats resist cancer, dermal γδ T cells aid in hair growth in rodents, and overexpression of IL-33 in mouse skin causes itchiness, offering a model for studying allergic inflammation treatments.

Betamethasone can effectively treat alopecia areata.

A young woman with a rare skin cancer was diagnosed late because her symptoms were unusual for the disease.

Accidentally eating a topical steroid may rarely cause acute generalized pustular psoriasis.

Two boys developed a viral skin infection during chemotherapy, which resolved with improved immune function.

CD4 T cells can cause alopecia areata by activating CD8 T cells to attack hair follicles.

JAK inhibitors like tofacitinib may effectively treat alopecia in children without major side effects.

Oral cyclosporine is more effective and safer than betamethasone for treating alopecia areata.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

Topical cyclosporine significantly extends skin graft survival in rats.

Oral tofacitinib can treat both psoriasis and alopecia universalis by normalizing inflammatory pathways.

Injecting triamcinolone acetonide near surgical cuts doesn't greatly affect wound healing but may help in areas with less tension.

Demodicosis should be considered in cats with facial skin issues exposed to inhalant glucocorticoids.

The medicine Cyclosporin A might cause excessive hair growth by reducing a protein that controls hair growth.

Isotretinoin reduced inflammation in tufted hair folliculitis, but hair tufting remained.